New speakers, exhibitors and neurogaming hackathon added to further explore the convergence of sensory and immersive technologies and gaming; Headliners include Palmer Luckey, Ed Fries, Robin Hunicke and more
FOR IMMEDIATE RELEASE
SAN FRANCISCO, CA March 5, 2014 – The Neurotechnology Industry Organization (NIO), a leading neuroscience trade association, today formally announced that its second annual NeuroGaming Conference and Expo will be held in San Francisco on May 7-8, 2014. The NeuroGaming Conference focuses on the convergence of mind and body with game play; using virtual reality, neurosensing, motion and gesture control, augmented reality, haptics, eye tracking, facial recognition and more cutting edge sensor technologies.
Following on the success of last year’s sold-out inaugural gathering, the NeuroGaming Conference has moved to a bigger venue, City View at Metreon, to accommodate demand. The two-day event brings together nearly 50 CEOs and executives speaking across twelve panels to share best practices, showcase new products and ideas, inspire each other and build new networks to help accelerate this rapidly emerging gaming sector. This year a neurogaming hackathon will precede the conference to foster development using the latest neurogaming technologies. Registration is now open at www.neurogamingconf.com.
“We had an amazing time last year bringing together some of the best minds in areas such as game design, sensor technology, health sciences and finance in an exchanging of ideas and a shared passion for this fascinating new industry sector,” said Zack Lynch, conference chair, author and neurotech visionary. “It’s exciting to see the industry embrace technologies like Oculus Rift and evolution of neurogaming just in one year’s time. So many people approached us afterward that wanted to be a part of this year’s conference, and we’ve sought out additional ways we can engage more people – and really the industry at large, into the conversation.”
The NeuroGaming Conference and Expo will showcase top experts, leading companies, and new technology for engaging and entertaining - including:
· Palmer Luckey, Founder, OculusVR the future of virtual reality play
· Ed Fries, Co-creator of the Xbox on secrets from the future
· Stanley Yang, CEO and Founder, NeuroSky on entertainment neurogaming
· Mike Ambinder, Valve on emotional gaming technologies
· Tan Le, CEO and Founder, Emotiv on neurosensing for wellness and entertainment
Neurogaming companies are integrating new inputs like player heart rate, brain waves, pupil dilation, hand and body gestures, and changing emotional state to drive rich game play. Neurogaming is ideally suited to take advantage of output technologies like augmented reality, virtual reality and haptic sensation systems to make entirely new gaming experiences possible. Many of the enabling technology companies will have their technology on display in the conference expo including: Emotiv, ViviTouch, Advanced Brain Monitoring, NeuroSky, Mindo, Throw Trucks with Your Mind, Intific, Leap Motion, faceshift, DAQRI, Blue Marble Brain Company, MindLight, Briim, Ontario Brain Institute, NeuroElectrics and many more.
Co-hosted by NeuroInsights, the neurotech market authority; the NeuroGaming Conference will take place on May 7-8 at City View at Metreon, located at 135 Fourth Street, San Francisco. A neurogaming hackathon is scheduled for the weekend prior to the main conference on May 3-4 in San Francisco, with up to $50,000 in prizes available for winning. For more information please visit www.neurogamingconf.com
About the Neurotechnology Industry Organization
The Neurotechnology Industry Organization is the trade association that represents companies involved in neuroscience including software, drugs, devices, and diagnostics, brain research institutes, and patient advocacy groups across the world. Since NIO's founding in 2006, over 100 organizations have joined NIO to "give the brain a voice." For more information, please visit www.neurotechindustry.org.
As the neurotech market authority, NeuroInsights helps investors, executives and governments understand and profit from the rapid growth of drugs, devices, software and diagnostics for the brain and nervous system. NeuroInsights' publications enable you to track market dynamics, develop investment strategies, identify partnering opportunities, and analyze comparables across the across this $160 billion global industry.